• The Role of Patient-Reported Outcome Measures in Value-Based Payment Reform

    Jun 1, 2017, 00:00

  • Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

    Jun 1, 2017, 00:00

  • The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs

    Jun 1, 2017, 00:00

  • Editorial Board

    Jun 1, 2017, 00:00

  • The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process

    Jun 1, 2017, 00:00

  • In this Issue

    Jun 1, 2017, 00:00

  • Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling

    Jun 1, 2017, 00:00

  • Copyright/Subscription

    May 1, 2017, 00:00

  • Editorial Board

    May 1, 2017, 00:00

  • 22nd International Abstracts Book

    May 1, 2017, 00:00

  • ToC

    May 1, 2017, 00:00

  • 22ND International Abstracts-FDS

    May 1, 2017, 00:00

  • Message from Co-Editors

    May 1, 2017, 00:00

  • Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical Routine

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Thresholds in Global Health- Taking a Multisectoral Perspective

    Apr 1, 2017, 00:00

  • Accounting for Cured Patients in Cost-Effectiveness Analysis

    Apr 1, 2017, 00:00

  • In this Issue

    Apr 1, 2017, 00:00

  • Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults

    Apr 1, 2017, 00:00

  • Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission- An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System

    Apr 1, 2017, 00:00

  • Eliciting Preferences for Information Provision in Newborn Bloodspot Screening Programs

    Apr 1, 2017, 00:00

  • Be Careful What You Ask For- Effects of Benefit Descriptions on Diabetes Patients’ Benefit-Risk Tradeoff Preferences

    Apr 1, 2017, 00:00

  • Table of Contents

    Apr 1, 2017, 00:00

  • A Practical ANOVA Approach for Uncertainty Analysis in Population-Based Disease Microsimulation Models

    Apr 1, 2017, 00:00

  • A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer

    Apr 1, 2017, 00:00

  • Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores

    Apr 1, 2017, 00:00

  • A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults- Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development

    Apr 1, 2017, 00:00

  • Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy- EQ-5D-3L and NEWQOL-6D

    Apr 1, 2017, 00:00

  • The PMA Scale- A Measure of Physicians’ Motivation to Adopt Medical Devices

    Apr 1, 2017, 00:00

  • Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials- Foundational Qualitative Research

    Apr 1, 2017, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment (HTA)- A Comparative Study of Six HTA Agencies

    Apr 1, 2017, 00:00

  • Editorial Board

    Apr 1, 2017, 00:00

  • Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models- Stop Developing, Start Evaluating

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years

    Apr 1, 2017, 00:00

  • The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule- Economic Evaluation

    Apr 1, 2017, 00:00

  • Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

    Apr 1, 2017, 00:00

  • Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States

    Apr 1, 2017, 00:00

  • Estimating an EQ-5D-5L Value Set for China

    Apr 1, 2017, 00:00

  • Copyright/Subscription

    Apr 1, 2017, 00:00

  • A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer

    Apr 1, 2017, 00:00

  • Balancing the Optimal and the Feasible- A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences

    Apr 1, 2017, 00:00

  • Determining Criteria and Weights for Prioritizing Health Technologies Based on the Preferences of the General Population- A New Zealand Pilot Study

    Apr 1, 2017, 00:00

  • External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD)- Report of the Third COPD Modeling Meeting

    Mar 1, 2017, 00:00

  • Time to Review the Role of Surrogate End Points in Health Policy- State of the Art and the Way Forward

    Mar 1, 2017, 00:00

  • Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer

    Mar 1, 2017, 00:00

  • Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus- Informing Economic Modeling

    Mar 1, 2017, 00:00

  • Emerging Guidelines for Patient Engagement in Research

    Mar 1, 2017, 00:00

  • Joint Utility Estimators in Substance Use Disorders

    Mar 1, 2017, 00:00

  • Constrained Optimization Methods in Health Services Research—An Introduction- Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force

    Mar 1, 2017, 00:00

  • ERRATUM

    Mar 1, 2017, 00:00

  • Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors’ Facility Residents

    Mar 1, 2017, 00:00

  • Editorial Board

    Mar 1, 2017, 00:00

  • Health State Utilities Associated with Glucose Monitoring Devices

    Mar 1, 2017, 00:00

  • Copyright/Subscription

    Mar 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly

    Mar 1, 2017, 00:00

  • Table of Contents

    Mar 1, 2017, 00:00

  • Real-World Data for the Evaluation of Transarterial Radioembolization versus Sorafenib in Hepatocellular Carcinoma- A Cost-Effectiveness Analysis

    Mar 1, 2017, 00:00

  • Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis- A Population-Based Study in Ontario, Canada

    Mar 1, 2017, 00:00

  • Psychometric Evaluation of a Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

    Mar 1, 2017, 00:00

  • Quality Control Process for EQ-5D-5L Valuation Studies

    Mar 1, 2017, 00:00

  • Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD

    Mar 1, 2017, 00:00

  • The Impact of China’s National Essential Medicine Policy and Its Implications for Urban Outpatients- A Multivariate Difference-in-Differences Study

    Mar 1, 2017, 00:00

  • The 3-Year Cost-Effectiveness of a Nurse-Based Case Management versus Usual Care for Elderly Patients with Myocardial Infarction- Results from the KORINNA Follow-Up Study

    Mar 1, 2017, 00:00

  • A Review of Patient-Reported Outcome Labeling in the United States (2011–2015)

    Mar 1, 2017, 00:00

  • The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation- A Systematic Review

    Mar 1, 2017, 00:00

  • Preference Weighting of Health State Values- What Difference Does It Make, and Why?

    Mar 1, 2017, 00:00

  • Treacle and Smallpox- Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment

    Mar 1, 2017, 00:00

  • In this Issue

    Mar 1, 2017, 00:00

  • An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands

    Mar 1, 2017, 00:00

  • Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan

    Mar 1, 2017, 00:00

  • Health Technology Assessment (HTA) Case Studies- Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland

    Mar 1, 2017, 00:00

  • Using Multicriteria Approaches to Assess the Value of Health Care

    Feb 1, 2017, 00:00

  • Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks

    Feb 1, 2017, 00:00

  • Comparing Increments in Utility of Health- An Individual-based Approach

    Feb 1, 2017, 00:00

  • Cost-Effectiveness and Dynamic Efficiency- Does the Solution Lie Within?

    Feb 1, 2017, 00:00

  • Developing a Value Framework- The Need to Reflect the Opportunity Costs of Funding Decisions

    Feb 1, 2017, 00:00

  • Value to Whom? The Patient Voice in the Value Discussion

    Feb 1, 2017, 00:00

  • Value Assessment in the Regulatory Context

    Feb 1, 2017, 00:00

  • Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

    Feb 1, 2017, 00:00

  • Advancing High-Quality Value Assessments of Health Care Interventions

    Feb 1, 2017, 00:00

  • Concerns Around Budget Impact Thresholds- Not All Drugs Are the Same

    Feb 1, 2017, 00:00

  • The Probabilistic Efficiency Frontier- A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options

    Feb 1, 2017, 00:00

  • Evaluating Frameworks That Provide Value Measures for Health Care Interventions

    Feb 1, 2017, 00:00

  • The HTA Core Model—10 Years of Developing an International Framework to Share Multidimensional Value Assessment

    Feb 1, 2017, 00:00

  • Copyright/Subscription

    Feb 1, 2017, 00:00

  • The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care- A Government Perspective Analytic Framework

    Feb 1, 2017, 00:00

  • Advancing Value Assessment in the United States- A Multistakeholder Perspective

    Feb 1, 2017, 00:00

  • Toward a Hedonic Value Framework in Health Care

    Feb 1, 2017, 00:00

  • Value Assessment Frameworks for HTA Agencies- The Organization of Evidence-Informed Deliberative Processes

    Feb 1, 2017, 00:00

  • Table of Contents

    Feb 1, 2017, 00:00

  • Toward a Broader Concept of Value- Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis

    Feb 1, 2017, 00:00

  • The Value of Addressing Patient Preferences

    Feb 1, 2017, 00:00

  • Using Cost-Effectiveness Analysis to Address Health Equity Concerns

    Feb 1, 2017, 00:00

  • Value Assessment at the Point of Care- Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values

    Feb 1, 2017, 00:00

  • Patient Versus Physician Valuation of Durable Survival Gains- Implications for Value Framework Assessments

    Feb 1, 2017, 00:00

  • The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems

    Feb 1, 2017, 00:00

  • New ISPOR Recommendations - Mapping Methods for Estimation of Health State Utility

    Jan 1, 2017, 00:00

  • Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury- A Systematic Review and Mapping Study

    Jan 1, 2017, 00:00

  • In This Issue

    Jan 1, 2017, 00:00

  • Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service

    Jan 1, 2017, 00:00

  • Reflections on ISPOR’s Clinician-Reported Outcomes Good Measurement Practice Recommendations

    Jan 1, 2017, 00:00

  • The Influence of Genotype Information on Psychiatrists’ Treatment Recommendations- More Experienced Clinicians Know Better What to Ignore

    Jan 1, 2017, 00:00

  • Economic Evaluations Comparing a Trial of Labor with an Elective Repeat Cesarean Delivery- A Systematic Review

    Jan 1, 2017, 00:00

  • The Challenge of Conditional Reimbursement- Stopping Reimbursement Can Be More Difficult Than Not Starting in the First Place!

    Jan 1, 2017, 00:00

  • Copyright/Subscription

    Jan 1, 2017, 00:00

  • Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures- An ISPOR Good Practices for Outcomes Research Task Force Report

    Jan 1, 2017, 00:00

  • Assessing the Value and Implications of Personalized/Precision Medicine and the “Lessons Learned” for Emerging Technologies- An Introduction

    Jan 1, 2017, 00:00

  • “What Goes Around Comes Around”- Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

    Jan 1, 2017, 00:00

  • A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease

    Jan 1, 2017, 00:00

  • Decision Making on Medical Innovations in a Changing Health Care Environment- Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

    Jan 1, 2017, 00:00

  • Budget Impact Analysis of Prolonged Half-Life Recombinant FVIII Therapy for Hemophilia in the United States

    Jan 1, 2017, 00:00

  • Variation in Health Technology Assessment and Reimbursement Processes in Europe

    Jan 1, 2017, 00:00

  • Costs and Outcomes of Increasing Access to Bariatric Surgery- Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records

    Jan 1, 2017, 00:00

  • Table of Contents

    Jan 1, 2017, 00:00

  • Estimating Preferences for Complex Health Technologies- Lessons Learned and Implications for Personalized Medicine

    Jan 1, 2017, 00:00

  • Incorporating Budget Impact Analysis in the Implementation of Complex Interventions- A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study

    Jan 1, 2017, 00:00

  • Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice

    Jan 1, 2017, 00:00

  • ERRATUM

    Jan 1, 2017, 00:00

  • Priority to End of Life Treatments? Views of the Public in the Netherlands

    Jan 1, 2017, 00:00

  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2017, 00:00

  • Clinician-Reported Outcome Assessments of Treatment Benefit- Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

    Jan 1, 2017, 00:00

  • Note to Editors

    Jan 1, 2017, 00:00

  • Results from a Well-Being Survey in the North West of England- Inequalities in EQ-5D–Derived Quality-Adjusted Life Expectancy Are Mainly Driven by Pain and Mental Health

    Jan 1, 2017, 00:00

  • Evaluation of COPD Treatments- A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States

    Jan 1, 2017, 00:00

  • The Burden of Obesity on Diabetes in the United States- Medical Expenditure Panel Survey, 2008 to 2012

    Jan 1, 2017, 00:00

  • Making Choices on the Journey to Universal Health Care Coverage- From Advocacy to Analysis

    Dec 1, 2016, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland

    Dec 1, 2016, 00:00

  • Economic Evaluations of Multicomponent Disease Management Programs with Markov Models- A Systematic Review

    Dec 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States

    Dec 1, 2016, 00:00

  • EQ-5D Scores for Diabetes-Related Comorbidities

    Dec 1, 2016, 00:00

  • Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants

    Dec 1, 2016, 00:00

  • Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

    Dec 1, 2016, 00:00

  • Table of Contents

    Dec 1, 2016, 00:00

  • Health Economics as Rhetoric- The Limited Impact of Health Economics on Funding Decisions in Four European Countries

    Dec 1, 2016, 00:00

  • A Differential Item Functioning Analysis of the EQ-5D in Cancer

    Dec 1, 2016, 00:00

  • Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes- A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years

    Dec 1, 2016, 00:00

  • Instructions for Authors

    Dec 1, 2016, 00:00

  • How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America

    Dec 1, 2016, 00:00

  • Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer- How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness

    Dec 1, 2016, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight

    Dec 1, 2016, 00:00

  • The International Decision Support Initiative Reference Case for Economic Evaluation- An Aid to Thought

    Dec 1, 2016, 00:00

  • Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores

    Dec 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia

    Dec 1, 2016, 00:00

  • Editorial Board

    Dec 1, 2016, 00:00

  • Copyright/Subscription

    Dec 1, 2016, 00:00

  • Country-Level Cost-Effectiveness Thresholds- Initial Estimates and the Need for Further Research

    Dec 1, 2016, 00:00

  • Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment

    Dec 1, 2016, 00:00

  • ERRATUM

    Dec 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail- An Empirical Analysis of 5 Years’ Experience

    Dec 1, 2016, 00:00

  • Using Patient-Reported Outcomes for Economic Evaluation- Getting the Timing Right

    Dec 1, 2016, 00:00

  • Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis

    Dec 1, 2016, 00:00

  • Benefits of Quitting Smoking in Japan on Working Productivity and Activity Impairment and Indirect Costs

    Nov 1, 2016, 00:00

  • Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia

    Nov 1, 2016, 00:00

  • The Current Status And Influential Factors of Insulin Pen Needle Reuse In T2D Patients From China

    Nov 1, 2016, 00:00

  • Barriers To Intravitreal Injection Therapy Adherence In Dme Patients In Australia

    Nov 1, 2016, 00:00

  • Indications For Prescription of Immodin®, Its Efficacy And Effect on The Most Commonly Examined Immunological Parameters

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ibrutinib For Waldenström Macroglobulinemia In Italy

    Nov 1, 2016, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • Clinical and Economic Benefits of a Community Pharmacy Vaccination Strategy

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of whole-Exome Sequencing in Complex Paediatric Neurology

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmaceutical Care Interventions on the Mean Daily Dose of Oral Antidiabetes Drugs in a Nigerian Tertiary Hospital

    Nov 1, 2016, 00:00

  • Fabrication of Anti-Vitiligo Ointment Containing Psoralia Corylifolia- Invitro and Invivo Characterization

    Nov 1, 2016, 00:00

  • The Effect of Reducing Cost-Sharing for Children on Utilization of Inpatient Services- Evidence From Japan

    Nov 1, 2016, 00:00

  • Impact of Safety-Related Regulation on Use of Codeine in Taiwanese Children

    Nov 1, 2016, 00:00

  • Making Pragmatic Trials Work

    Nov 1, 2016, 00:00

  • Adherence To Vancomycin Therapeutic Guidelines At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • The Comparisons of Biologics with Methotrexate for Treating Rheumatoid Arthritis Patients in Taiwan- The use of Cost-Utility Analysis and Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Effectiveness of A Renal Protection Program In Patients with Hypertension and/or Diabetes Mellitus Type II In Colombia

    Nov 1, 2016, 00:00

  • Intravenous Fluids for Children- Cost and Threshold Analysis to Inform the National Institute for Health and Care Excellence (NICE) Clinical Guideline Recommendation

    Nov 1, 2016, 00:00

  • Self-Care Behavior And Medication Use Of Buddhist Monks With Diabetes Mellitus In Phasi Charoen, Bangkok

    Nov 1, 2016, 00:00

  • Concentration Analysis Of Hungarian Health Care Providers Between 2006-2015

    Nov 1, 2016, 00:00

  • Cost-Effectiveness and Cost-Utility of Intralesional Recombinant Human Epidermal Growth Factor for Adjuvant Treatment of Wagner’s 3 and 4 Diabetic Foot Ulcers

    Nov 1, 2016, 00:00

  • Relevance And Economic Consequences Of Medicine Waste In Vienna- Analysis Of A Household Garbage Sample

    Nov 1, 2016, 00:00

  • Drug Utilisation of Braf Inhibitors for Melanoma in Ireland

    Nov 1, 2016, 00:00

  • The Influence of Glycemic Control in the Quality of Life of Type 2 Diabetes Mellitus Patients in Greece-the Hypo2 Study

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Mapping Quality of Life Scores from FACT-G, FAACT And FACIT-F Onto Preference-Based Utilities Using the 5-Level Version of EQ-5D Questionnaire

    Nov 1, 2016, 00:00

  • Caesarean Section In Xindu County of Chengdu, China- Trend And Its Correlates From 2008 to 2014

    Nov 1, 2016, 00:00

  • Hepatitis B Vaccination in Dialysis Patients. Is it Really Protective?

    Nov 1, 2016, 00:00

  • Validation Of Comorbidity Indices (Charlson And Elixhauser) Computed In Cross Sectional Hospital Billing Data

    Nov 1, 2016, 00:00

  • Replacing Input Probability Distributions with Mean Values can Bias Simulation Output- An Illustration Using the Core Diabetes Model

    Nov 1, 2016, 00:00

  • Romanian Claw-Back Taxation- From A Financial Solution to A Challenge for Patients Access to Drugs

    Nov 1, 2016, 00:00

  • Comparison of Health Care Utilization And Cost Depending on The Severity of Asthma in Adults- Analysis of The Korean National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Policy Evaluation on“The Pay-For-Performance Program of Hepatitis B and C” in Taiwan

    Nov 1, 2016, 00:00

  • Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015

    Nov 1, 2016, 00:00

  • The Predirtion of The Brca1/2-Related Ovarian Cancer Morbility In Russia

    Nov 1, 2016, 00:00

  • Psychometric Properties of The Chinese Version of Problem Areas In Diabetes Scale (Sg-Paid-C) Among High-Risk Polypharmacy Patients With Uncontrolled Type 2 Diabetes In Singapore

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Indonesian Asthma Patients

    Nov 1, 2016, 00:00

  • Polypharmacy and Medication Adherence in Elderly Patients with Diabetes in Pafos General Hospital, Cyprus

    Nov 1, 2016, 00:00

  • International Pediatric Hospital Patient Outcomes

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection Treatment for Gastric Adenoma in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • General Public Knowledge and Awareness About Medicines Use in Penang, Malaysia

    Nov 1, 2016, 00:00

  • Generating Consistent and Reliable Evidence on Survival Estimates for Health Technology Assessment in Oncology and Haematology

    Nov 1, 2016, 00:00

  • Influencing Factors On Knowledge, Attitude And Behaviour Towards Antibiotic Usage Among Adults In Ho Chi Minh City, Viet Nam

    Nov 1, 2016, 00:00

  • EQ-5D Utility Value Sets for Sri Lanka- A Case For Economic Evaluations in South Asia

    Nov 1, 2016, 00:00

  • The First Indonesian Health-Related Quality of Life Valuation Study- An Eq-5d-5l Value Set

    Nov 1, 2016, 00:00

  • Cost-Outcome Analysis of Different Intravenous Iron Sucrose Preparations in Hemodialysis Patients

    Nov 1, 2016, 00:00

  • A Study of Prescription Pattern of Non Steroidal Anii-Inflammatory Drugs in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Prescribing Behaviour And Drug Use In Pakistan

    Nov 1, 2016, 00:00

  • Setting Recommendations for Good Practice of Health Technology Assessment in the Egyptian Ministry of Health

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Incorporation of A Computerized Temperature Management System In The Treatment of Therapeutic Hypothermia In Greece

    Nov 1, 2016, 00:00

  • Qualitative Research Approaches In Rare Diseases- Acid Sphingomyelinase Deficiency (ASMD) Symptoms and Impact as Reported by Patients and Caregivers

    Nov 1, 2016, 00:00

  • Ankylosing Spondylitis is Associated with Significant Increases in Healthcare Resource Utilization And Costs in A German Real World Setting

    Nov 1, 2016, 00:00

  • Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Two New Cancer-Specific Multi-Attribute Utility Instruments- EORTC QLU-C10D and FACT-8D

    Nov 1, 2016, 00:00

  • Adoption of Managed Entry Agreements in Established and Emerging Markets

    Nov 1, 2016, 00:00

  • Considerations in Meta-Analytic Network Design- The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- Past, Present and Future

    Nov 1, 2016, 00:00

  • Direct Costs, Work Productivity Loss, And Effectiveness of Treatment Of Rheumatoid Arthritis (RA) Patients Through A Treat-To-Target (T2T) Approach- A Real-World Administrative Database Analysis

    Nov 1, 2016, 00:00

  • Recommended vs Reimbursed vs Actually used Chemiotherapeutics in Pancreatic Adenocarcinoma in Poland

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Patients with Metastatic Merkel Cell Carcinoma Treated with Second-Line or Later Chemotherapy in A Community Oncology Setting in The United States

    Nov 1, 2016, 00:00

  • Specialty Pharmacy, Diagnostic, And Genetic Testing Coverage In The United States

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving while Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in Belgium- A Cost-Utility Study

    Nov 1, 2016, 00:00

  • The Health Economics Analysis of Unqualified Venous Blood Samples In The Chinese Tertiary Referral Hospital

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rivaroxaban Within Subgroups for Atrial Fibrillation and Venous Thromboembolism in The Netherlands

    Nov 1, 2016, 00:00

  • Cost-Efficiency Of Medication Safety Program At Pediatrics, Obstetrics, And Gynecology Hospital, East Province, Saudi Arabia

    Nov 1, 2016, 00:00

  • A Systematic Review on Methodological Heterogeneity in Estimating Productivity Loss Associated with Colorectal Cancer

    Nov 1, 2016, 00:00

  • Willingness To Pay For Primary Dysmenorrhea Health States

    Nov 1, 2016, 00:00

  • Severe ulcerative collitis in children and adolescents in poland – it’s time to catch up with Europe. Budget impact analysis (Bia) for biosimilar infliximab

    Nov 1, 2016, 00:00

  • Impact Of Burdensome Chronic Conditions On Health-Related Quality Of Life Among Europeans- Analysis Of Eq-5d-5l Vas Scores

    Nov 1, 2016, 00:00

  • Pro Instruments for Musculoskeletal Disorders used in Studies Published Since 2005- Which Diseases have had the most Tools Developed?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Tiotropium Versus Glycopyrronium In Moderate To Very Severe COPD In France

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom

    Nov 1, 2016, 00:00

  • The Current Treatment of Parkinson's Disease in Japan

    Nov 1, 2016, 00:00

  • Satisfaction Level of Patients, Physicians, and Private Primary Healthcare Center Managers with Chronic Disease Management Program in Indonesia

    Nov 1, 2016, 00:00

  • High-Sensitivity C-Reactive Protein Measurements in Patients with a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • An a Priori Decision Criteria Elicitation Method for Treatment Decision-Making in Elderly Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Comparison Of Web-Based Signal Detection Using Medical Forums Data In France From 2005-2015 With Signals From Vigibase®

    Nov 1, 2016, 00:00

  • Closed-System Transfer Device for Preparation of Antineoplastic Drugs in a Malaysian Public Hospital- Is it Truly Cost Saving?

    Nov 1, 2016, 00:00

  • Predictors of First Line Treatment Persistence Among Patients with Metastatic Renal Cell Carcinoma in The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • Innovative Medical Device Design Significantly Reduces Surgeon Intra-Procedural Stress Levels (Ipsl)

    Nov 1, 2016, 00:00

  • Systematic Literature Review of Utility Data For House Dust Mite-Induced Allergic Asthma and/or Allergic Rhinitis

    Nov 1, 2016, 00:00

  • Economic Consequences Of The Choices In Injectable Anticoagulants In France

    Nov 1, 2016, 00:00

  • Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Non-Invasive Vagus Nerve Stimulation As A Treatment For Headache Patients with Multi-Morbidity- Real World Experience In English Primary Care

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab in Combination with Ipilimumab for the Treatment of Advanced Melanoma Patients in England

    Nov 1, 2016, 00:00

  • Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost Burden of Crohn's Disease and Ulcerative Colitis in the United States

    Nov 1, 2016, 00:00

  • Can Acute Phase Clinical Outcomes Predict Health-Related Quality of Life After Stroke?

    Nov 1, 2016, 00:00

  • Prevalence and Characteristics of Mental Disorders Among Hospitalized Breast Cancer Patients in the United States

    Nov 1, 2016, 00:00

  • Economic Analyses of Diagnostic Tests for HCC Surveillan A Systematic Review

    Nov 1, 2016, 00:00

  • The Social Cost of Major Depression

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Overactive Bladder Treatment with Mirabegron in Patients in South Korea

    Nov 1, 2016, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates For Melanoma Drugs in Poland

    Nov 1, 2016, 00:00

  • General Practitioners Awareness On Medicines Cost And Financing In Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes

    Nov 1, 2016, 00:00

  • Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)

    Nov 1, 2016, 00:00

  • Attitude towards the use of complementary and alternative medicines (cam) among pharmacy and medical students. A comparative study

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia

    Nov 1, 2016, 00:00

  • Cost of Ebola Virus Disease Diagnosis Using Rapid Point-Of-Care Diagnostics in Sierra Leone

    Nov 1, 2016, 00:00

  • Perceptions of Thalassemia Patients' on Thalassemia and Its Treatment- A Qualitative Exploration

    Nov 1, 2016, 00:00

  • Social Media- A Valuable Tool to Assess Patient Perspectives Regarding Quality of Life

    Nov 1, 2016, 00:00

  • A Proposed Model for the Study of the Longitudinal Behavior of Prevalence Rates

    Nov 1, 2016, 00:00

  • Medication Cost Of Acute Myeloid Leukemia- A Descriptive Study

    Nov 1, 2016, 00:00

  • The Trend of High Dose Insulin Initiated Among Diabetes Patients in UK

    Nov 1, 2016, 00:00

  • Rescaling The Overall Score In The Cervantes Short-Form Scale For Measuring Health-Related Quality Of Life In Menopausal Women Sexually Inactive

    Nov 1, 2016, 00:00

  • Trends in The Utilization, Spending, and Prices For Smoking Cessation and Nicotine Replacement Products In US Medicaid Programs- 1991–2015

    Nov 1, 2016, 00:00

  • Management of Soft Tissue Sarcoma in France - A Retrospective Analysis of The French Clinical Biological Sarcoma Database (CONTICANET)

    Nov 1, 2016, 00:00

  • Do Nutrition Interventions Require a Different Approach to Economic Evaluation?

    Nov 1, 2016, 00:00

  • Have the NHS Health Checks been Unfairly Maligned?

    Nov 1, 2016, 00:00

  • The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review

    Nov 1, 2016, 00:00

  • Assessment of Knowledge and Perception Regarding Breast Cancer Among Patients Attending Gynecological Department of Tertiary Care Hospital in Quetta Pakistan

    Nov 1, 2016, 00:00

  • Burden of Disease and Healthcare Costs of Patients Treated with Antiglaucoma Drugs

    Nov 1, 2016, 00:00

  • Cost Effectiveness Of Ivacaftor And Lumacaftor Combination For The Treatment Of Patients With Cystic Fibrosis In The United States

    Nov 1, 2016, 00:00

  • A Systematic Review of Utility Derivation Methods- Time Trade off in Comparison to EQ-5D

    Nov 1, 2016, 00:00

  • Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Differences in Perception of Health-Related Quality of Life Associates to Socioeconomic, Cultural and Housing Factors- Multilevel Analysis

    Nov 1, 2016, 00:00

  • Health Care Costs, Lenght Of Stay And Mortality Of Carbapenem Resistance Gram-Negative Bacteremia

    Nov 1, 2016, 00:00

  • Impaired Quality Of Life After Chikungunya Virus Infection- A 12-Months Follow-Up Study Of Its Chronic Inflammatory Rheumatism In La Virginia, Risaralda, Colombia

    Nov 1, 2016, 00:00

  • Effect of Clinical Pharmacist in Patient Safety-A Prospective Interventional Study

    Nov 1, 2016, 00:00

  • Budget Impact Model of Secukinumab In The Treatment of Ankylosing Spondylitis (AS) And With Psoriatic Arthritis (PSA) In Italy

    Nov 1, 2016, 00:00

  • Risk of Mortality and Hospital Readmission Among Older Adults with Heart Failure Treated with Carvedilol, Bisoprolol or Metoprolol Tartrate

    Nov 1, 2016, 00:00

  • Economic Burden Of Diseases In Fran Analysing The Trends From 2012 To 2014, Using The French Health Insurance Database (Sniiram)

    Nov 1, 2016, 00:00

  • Real World Tolerability And Effectiveness of Exenatide Once-Weekly Compared To Basal Insulin Among Elderly Patients with Type 2 Diabetes (T2D)

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization (HCRU) in Relapsed/Refractory Multiple Myeloma (RRMM)- Comparison of EU and US Cohorts in the Preamble Study

    Nov 1, 2016, 00:00

  • A Systematic Literature Review (Slr) of Health-Economic Evaluations of Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • Utilisation of Antiretrovirals in the Slovak Republic - A 10-Year Retrospective Study

    Nov 1, 2016, 00:00

  • Perliminary Study of Medication Regimen Complexity Among Taiwanese Elderly who Have Used Anxiety or Hypnotics Prescriptions

    Nov 1, 2016, 00:00

  • Key Aspects in the Modelling of Dengue Transmission- Results from a Focused Literature Review

    Nov 1, 2016, 00:00

  • The Prevalence of Plaque Psoriasis, Psoriatic Arthritis And The Overlap Between Them In Norway

    Nov 1, 2016, 00:00

  • Asthma in Fran Analysis of 2015 National Health and Wellness Survey Data

    Nov 1, 2016, 00:00

  • Subject Recommendations for Improving Their Compliance in Completing Electronic Diaries in Depression Clinical Trials

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Using Pazopanib in First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Are us Private Payers' Medical Policies Influenced by Cochrane Evidence?

    Nov 1, 2016, 00:00

  • The Use of Consensus Techniques to Inform Health Technology Appraisals

    Nov 1, 2016, 00:00

  • Budget-Impact Analysis (Bia) Of The Introduction Of 52mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) As A Contraceptive Method Option In The Brazilian Public Healthcare System (Sus) To Avoid Unintended Pregnancy (Up) In 15 To 19 ...

    Nov 1, 2016, 00:00

  • Programme Budgeting Marginal Analysis for the Real World- The ‘Prudent Pbma’

    Nov 1, 2016, 00:00

  • Value Added Medicines- The Need To Establish One Common Terminology For Repurposed Medicines

    Nov 1, 2016, 00:00

  • The Situate Detection System - A Cost-Effective Approach to Preventing Retained Surgical Sponges

    Nov 1, 2016, 00:00

  • Two-Year Antecedent Versus Subsequent Diagnoses of Patients Newly Diagnosed with Primary Restless Legs Syndrome- A Large-Scale Retrospective Claims Analysis

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Pharmacist-Provided Home-Based Medication Review in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Rare Disease Treatment Recommendations in the UK- What Limitations and Requests are Imposed as Part of Nice HST Guidance?

    Nov 1, 2016, 00:00

  • Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets

    Nov 1, 2016, 00:00

  • A Retrospective Analysis of Heart Failure Prescription Adherence and the Hospitalization Outcome- A Tertiary Medical Center Experience in Taiwan

    Nov 1, 2016, 00:00

  • Comparison Of Biosimilar Guideline And Real Consumption Among Italian Regions

    Nov 1, 2016, 00:00

  • Long-Term Follow-Up of Ranibizumab Treated Patients with Myopic Choroidal Neovascularization from the Radiance Clinical Trial in Four East Asian Countries

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Value of Febuxostat For The Treatment of Persistent Hyperuricaemia- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Ethical Standards In Reporting Research From Retrospective Observational Studies Based On Databases Using Anonymous And Personally Unidentifiable

    Nov 1, 2016, 00:00

  • Higher Weight, Higher Burden- Outcomes Of Adults In Japan With Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Hypoglycemia in Patients with Type 1 and Type 2 Diabetes Mellitus in Austria

    Nov 1, 2016, 00:00

  • Factors Associated with Glycemic Control and Diabetes-Related Costs in Patients with Diabetes in the United Arab Emirates- Results From A Retrospective Large Claims Data Analysis

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis- Treatment Sequencing in Guidelines Compared to Real-World Evidence. A German Claims Data Analysis

    Nov 1, 2016, 00:00

  • Linkage Of The Pharmo Database Network And The Netherlands Perinatal Registry To Construct A Cohort That Captures Pregnancy And Postnatal Outcomes

    Nov 1, 2016, 00:00

  • Epidemiology and Costs of Psoriasis in Germany – A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in Spain

    Nov 1, 2016, 00:00

  • Assessing the Broader Economic Consequences of Hpv Prevention in Indonesia Using a Government Perspective Fiscal Analytic Method

    Nov 1, 2016, 00:00

  • The Impact on Access to Innovative Drugs of The First Managed Entry Agreements in Romania

    Nov 1, 2016, 00:00

  • The Cost Of Illness of Ultra-Rare Cryopyrin Associated Periodic Syndromes (CAPS) In Italy- Preliminary Results From The Radicea Project

    Nov 1, 2016, 00:00

  • A Barriers to and Facilitators of the use of HTA Reports by Policymakers in Kazakhstan

    Nov 1, 2016, 00:00

  • Stakeholders Views On The Role Of Hta And Rsas In Pharmaceutical Policy In Greece

    Nov 1, 2016, 00:00

  • The Transparency Of Published Recommendations On Reimbursement Of Health Technologies In Poland

    Nov 1, 2016, 00:00

  • Costs and Benefits of Home Food Industry Issuance Program in Indonesia

    Nov 1, 2016, 00:00

  • Reliability and Validity Study of the Finnish Adaptation of Scoliosis Research Society Questionnaire Version SRS-30

    Nov 1, 2016, 00:00

  • Impact Of Us Health Exchanges (Hix) On The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • A Model-Based Cost-Effectiveness Analysis of B-Type Natriuretic Peptide Monitoring in Patients with Heart Failure

    Nov 1, 2016, 00:00

  • A Review of Assessments of The Quality of Pharmacoeconomic Evaluations in China

    Nov 1, 2016, 00:00

  • Quetiapine Off-Label Use

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Using Stent-Retriever After Intravenous T-PA Compared with Intravenous T-PA Alone in The Treatment of Acute Ischemic Stroke Due to Large Vessel Occlusion in Spain

    Nov 1, 2016, 00:00

  • Cancer Drugs in The EU5 and USA- Cross-Country Pricing Comparison and Correlation Analysis Between Overall Survival (OS) and Progression-Free Survival (PFS)

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of Hydrophilic Coated Versus Non-Coated Urinary Catheters for Intermittent Use in Japan

    Nov 1, 2016, 00:00

  • Literature Review On Morbidity and Mortality Endpoints in Melanoma Patients Under Treatment With GM-CSF or Dacarbazine

    Nov 1, 2016, 00:00

  • Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes

    Nov 1, 2016, 00:00

  • Are Criteria Commonly Used in the Benefit Assessment of Drugs also Applicable to Medical Devices? - A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Can Pharmaceutical Care Intervention Improve Lipid Profile in Type 2 Diabetes Patients; A Prospective Intervention Study in a Tertiary Hospital in Nigeria

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Take Home-Naloxone for the Prevention Of Fatalities from Heroin Overdose in the UK

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients with Type 2 Diabetes Mellitus in Taiwan

    Nov 1, 2016, 00:00

  • Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy

    Nov 1, 2016, 00:00

  • Assessing Statin-Associated Myopathy using Administrative Data from a German Health Insurance Fund- Results of a Pilot Study

    Nov 1, 2016, 00:00

  • Segmentation of Seven Asia-Pacific Health Technology Assessment (HTA) Agencies into Different Evolutionary HTA Archetypes

    Nov 1, 2016, 00:00

  • Standardisation and Compatibility Between HTA Networks- what Impacts on Quality?

    Nov 1, 2016, 00:00

  • Case Duration As A Surgical Quality And Efficiency Indicator In Surgical Residency Training Programs

    Nov 1, 2016, 00:00

  • Why is the Herd Protection Level Higher in the UK than in Belgium after the Introduction of the Rotavirus Vaccine?

    Nov 1, 2016, 00:00

  • Cost of Outreach-Programme Toward Sex Workers in the NGO and Primary Health Center in Indonesia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pazopanib Compared to Sunitinib In the Treatment of Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Excess Costs Associated With Obstructive Sleep Apnea In The Elderly

    Nov 1, 2016, 00:00

  • Contrasting The Characteristics Of Hta Submissions For Rare Versus Ultra-Rare Diseases

    Nov 1, 2016, 00:00

  • Need of Cosmetovigilance in India

    Nov 1, 2016, 00:00

  • Study Care Costs and Use of Health Technologies for Patients with Hemophilia a Health System Affiliates in Colombia

    Nov 1, 2016, 00:00

  • Direct Costs Associated to Meningococcal Disease and Related Sequelae in Children – Analysis Based on the Brazilian Public Health System Perspective

    Nov 1, 2016, 00:00

  • The Impact of Ischemic Stroke on Atrial Fibrillation-Related Healthcare Cost- A Systematic Review

    Nov 1, 2016, 00:00

  • Effectiveness And Cost-Effectiveness of The Salut Programme – A Universal Health Promotion Intervention For Parents And Children

    Nov 1, 2016, 00:00

  • Reliability and Convergent Validity of The Nei Vfq-25 with and Without Near and Distance Activity Appendix Items In Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

    Nov 1, 2016, 00:00

  • Comparison Of Time To Reimbursement Decision Of Innovative Pharmaceuticals In Europe

    Nov 1, 2016, 00:00

  • One-Year Follow-Up of Medication Regimen Complexity Among Moderate Copd Patients with or Without Earlier Use Of Inhaled Corticosteroids

    Nov 1, 2016, 00:00

  • Markov Model Projection Of Regional Physician Supply In Turkey Shows That Physician Density Will Not Change Substantially In The Next 15 Years

    Nov 1, 2016, 00:00

  • Role Of Tuberculosis Home Observer In Improving Clinical Outcome Of Patient In Yemen

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance) in the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM) in the UK Based on Empa-Reg Outcome Data

    Nov 1, 2016, 00:00

  • Factors Influencing Attitudes to Colorectal Cancer Screening

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Thrombolytic Agents Streptokinase, Alteplase and Tenecteplase in the Treatment of Acute Myocardial Infarction

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Telemonitoring in Gynaecology and Obstetrics

    Nov 1, 2016, 00:00

  • Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • The Economic Impact of Early Exit From Work Attributable To Osteoarthritis

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies in Progressive Supranulcear Palsy (PSP) in North America, Europe and Japan

    Nov 1, 2016, 00:00

  • Economic Burden of Advanced Gastric Cancer (AGC) in Mexico

    Nov 1, 2016, 00:00

  • Reasons for Switching Treatment Among Severe Hemophilia A and B Adults in Europe

    Nov 1, 2016, 00:00

  • A Systematic Literature Review On The Drivers of Effectiveness and The Efficacy-Effectiveness Gap in Hematological Malignancies with A Focus On Hodgkin’s Lymphoma

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Yellow Fever Routine Vaccination In Colombia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Sofosbuvir For Genotype 2 Hepatitis C In Greece

    Nov 1, 2016, 00:00

  • Burden of osteoporosis-related hip fracture in asia. A review of health care costs and resource utilization

    Nov 1, 2016, 00:00

  • Appropriate Analysis of the Additional Costs of Antibiotic Resistan The Impact of Different Biases

    Nov 1, 2016, 00:00

  • Market Share of Addictology According To The System of Diagnosis Related Groups (DRGS) In Hungary

    Nov 1, 2016, 00:00

  • For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Assessment Of General Knowledge Concerning Health-Related Topics

    Nov 1, 2016, 00:00

  • Retrospective Claims Database Analysis to Explore Differences in Heart Failure Patients with and without Iron Deficiency or Anemia

    Nov 1, 2016, 00:00

  • Non-Valvular Atrial Fibrillation- Can We Improve Health Outcomes?

    Nov 1, 2016, 00:00

  • Not All Cochrane Reviews Are Good Quality Systematic Reviews

    Nov 1, 2016, 00:00

  • Cost Consequence Analysis of Sitagliptin +Metformin Vs Sulfonylureas+Metformin in Type 2 Diabetic Patients in Italy

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Use of Extended Half-Life Recombinant Factor VIII (EFMOROCTOG ALFA) For The Treatment of Congenital Haemophilia A- The Italian National Health System Perspective

    Nov 1, 2016, 00:00

  • Evaluation of Breast Cancer HER2 Status Accuracy Using A Predictive Model Based on Her-France Real World National Database

    Nov 1, 2016, 00:00

  • Household Cost Of Injuries in Children Under Five Years in the Ejisu-Juabeng Municipality of the Ashanti Region, Ghana- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism

    Nov 1, 2016, 00:00

  • Extension Of The Labels Within The Eq-5d-Y

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Short-Form 36 (SF-36) Health Survey in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • Discharge Prescription Patterns of Antipsychotics In Patients With Mental Illness Hospitalized Compulsorily By Prefectural Governors

    Nov 1, 2016, 00:00

  • Effects Of Pharmacist Counseling on Outpatients Receiving Warfarin at Dr. Hasan Sadikin Bandung Hospital

    Nov 1, 2016, 00:00

  • Challenges in the Health Economics of Acute Pain- A Rapid Review of the Literature

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- Multicenter Cohort Study

    Nov 1, 2016, 00:00

  • Determining Criteria and Weights for Prioritising Health Technologies Based on the Preferences of the General Population- A New Zealand Pilot Study

    Nov 1, 2016, 00:00

  • HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain)- Pilot Study Focused in Orphan Drugs

    Nov 1, 2016, 00:00

  • Italian Electronic Health Records Mapping- Is Clinical Data Collection Getting In Line With The Real World Evidence Era?

    Nov 1, 2016, 00:00

  • Amnog Early Benefit Assessment (EBA) in Germany - A Specific Challenge for Antidiabetics

    Nov 1, 2016, 00:00

  • Prescription Patterns And Costs Of Migraine Therapy In Germany

    Nov 1, 2016, 00:00

  • Do We Really Know when We Should Screen for Hepatitis B C before Starting Immunosuppressive Therapy ?

    Nov 1, 2016, 00:00

  • Treatment Patterns And Healthcare Costs of Rheumatoid Arthritis (RA) Patients In Italy

    Nov 1, 2016, 00:00

  • Impacts of Adverse Events on Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer- Results From Randomized Phase III Select BC Study

    Nov 1, 2016, 00:00

  • Adherance To Medication Errors Repoting System At Public Hospital, Riyadh, Saudi Arabia

    Nov 1, 2016, 00:00

  • Direct Economic Burden in Patients with Cerebral Venous Thrombosis at A Tertiary Care Hospital in South India

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ibrutinib in Adult Patients with Relapsed Chronic Lymphocytic Leukaemia in the Netherlands

    Nov 1, 2016, 00:00

  • Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence to Their Oral Treatment- Iphodia, A Cluster Randomized Study Vs Usual Practice

    Nov 1, 2016, 00:00

  • Improving Access to Psychological Therapies in British Sign Language (BSL)- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Analysis on the Regional Distribution of Telemedicine in China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Dapagliflozin Versus Acarbose as A Monotherapy in Type 2 Diabetes in China

    Nov 1, 2016, 00:00

  • Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia

    Nov 1, 2016, 00:00

  • Translation of Chinese Version of Measure Yourself Medical Outcome Profile (MYMOP) And Application In The Coronary Heart Disease

    Nov 1, 2016, 00:00

  • Cost and Burden of Female Breast Cancer in Portugal

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73 (current)
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »